• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

COVID-19 大流行第一年美沙酮类物质处方的变化。

Changes in Buprenorphine Prescribing to Medicaid Beneficiaries During the First Year of the COVID-19 Pandemic.

机构信息

Community Health Research Division, RTI International, Research Triangle Park, North Carolina.

出版信息

JAMA Netw Open. 2022 Mar 1;5(3):e224058. doi: 10.1001/jamanetworkopen.2022.4058.

DOI:10.1001/jamanetworkopen.2022.4058
PMID:35323952
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8948527/
Abstract

This cross-sectional study compares trends in prescribing buprenorphine to all Medicaid beneficiaries before and after the start of the COVID-19 pandemic.

摘要

本横断面研究比较了 COVID-19 大流行前后开处丁丙诺啡给所有医疗补助受益人的处方趋势。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/183c/8948527/72c5a0591fda/jamanetwopen-e224058-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/183c/8948527/247ab83e6270/jamanetwopen-e224058-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/183c/8948527/72c5a0591fda/jamanetwopen-e224058-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/183c/8948527/247ab83e6270/jamanetwopen-e224058-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/183c/8948527/72c5a0591fda/jamanetwopen-e224058-g002.jpg

相似文献

1
Changes in Buprenorphine Prescribing to Medicaid Beneficiaries During the First Year of the COVID-19 Pandemic.COVID-19 大流行第一年美沙酮类物质处方的变化。
JAMA Netw Open. 2022 Mar 1;5(3):e224058. doi: 10.1001/jamanetworkopen.2022.4058.
2
The intertwined expansion of telehealth and buprenorphine access from a prescriber hub.从一个开处方的枢纽来看，远程医疗和丁丙诺啡获取的交织扩张。
Prev Med. 2021 Nov;152(Pt 2):106603. doi: 10.1016/j.ypmed.2021.106603. Epub 2021 May 8.
3
Buprenorphine maintenance treatment in patients with opioid use disorder diagnosed with COVID-19.COVID-19 诊断为阿片类药物使用障碍的患者的丁丙诺啡维持治疗。
J Opioid Manag. 2020 Nov-Dec;16(6):405-407. doi: 10.5055/jom.2020.0598.
4
Leveraging pharmacists to maintain and extend buprenorphine supply for opioid use disorder amid COVID-19 pandemic.利用药剂师在 COVID-19 大流行期间维持和扩大阿片类药物使用障碍的丁丙诺啡供应。
Am J Health Syst Pharm. 2021 Mar 18;78(7):613-618. doi: 10.1093/ajhp/zxab003.
5
Association of Buprenorphine-Waivered Physician Supply With Buprenorphine Treatment Use and Prescription Opioid Use in Medicaid Enrollees.美沙酮处方医师人数与医疗补助计划参保者美沙酮治疗使用和处方类阿片药物使用的关联。
JAMA Netw Open. 2018 Sep 7;1(5):e182943. doi: 10.1001/jamanetworkopen.2018.2943.
6
Buprenorphine Opioid Treatment During the COVID-19 Pandemic.新冠疫情期间的丁丙诺啡阿片类药物治疗
JAMA Intern Med. 2021 Aug 1;181(8):1135. doi: 10.1001/jamainternmed.2021.0777.
7
Rapid upscale of depot buprenorphine (CAM2038) in custodial settings during the early COVID-19 pandemic in New South Wales, Australia.在澳大利亚新南威尔士州新冠疫情早期，拘留场所中丁丙诺啡长效注射剂（CAM2038）的快速推广。
Addiction. 2021 Feb;116(2):426-427. doi: 10.1111/add.15244. Epub 2020 Sep 21.
8
Buprenorphine Opioid Treatment During the COVID-19 Pandemic-Reply.COVID-19大流行期间的丁丙诺啡阿片类药物治疗——回复
JAMA Intern Med. 2021 Aug 1;181(8):1135-1136. doi: 10.1001/jamainternmed.2021.0774.
9
Buprenorphine Dispensing in Pennsylvania During the COVID-19 Pandemic, January to October 2020.2020年1月至10月新冠疫情期间宾夕法尼亚州的丁丙诺啡配药情况
J Gen Intern Med. 2021 Dec;36(12):3915-3917. doi: 10.1007/s11606-021-07083-y. Epub 2021 Aug 10.
10
Prescribing of Opioid Analgesics and Buprenorphine for Opioid Use Disorder During the COVID-19 Pandemic.COVID-19 大流行期间阿片类药物使用障碍的阿片类镇痛药和丁丙诺啡的处方
JAMA Netw Open. 2021 Apr 1;4(4):e216147. doi: 10.1001/jamanetworkopen.2021.6147.

引用本文的文献

1
Exploring the Lived Experiences of Medication for Opioid use Disorder Treatment: A Qualitative Study among a Crowdsourced Convenience Sample.探索阿片类物质使用障碍治疗药物的生活体验：一项众包便利样本的定性研究
Community Ment Health J. 2025 Apr;61(3):411-419. doi: 10.1007/s10597-024-01345-9. Epub 2024 Sep 5.
2
Composition of buprenorphine prescribing networks in Medicaid and association with quality of care.医疗补助计划中丁丙诺啡处方网络的构成及其与医疗质量的关联。
J Subst Use Addict Treat. 2024 Aug;163:209363. doi: 10.1016/j.josat.2024.209363. Epub 2024 Apr 18.
3
Risks of opioid overdose among New York State Medicaid recipients with chronic pain before and during the COVID-19 pandemic.

本文引用的文献

1
COVID-19 Adaptations in the Care of Patients with Opioid Use Disorder: a Survey of California Primary Care Clinics.阿片类物质使用障碍患者护理中的新冠疫情应对措施：加利福尼亚州基层医疗诊所调查
J Gen Intern Med. 2021 Apr;36(4):998-1005. doi: 10.1007/s11606-020-06436-3. Epub 2021 Jan 28.
2
Assessment of Filled Buprenorphine Prescriptions for Opioid Use Disorder During the Coronavirus Disease 2019 Pandemic.评估 2019 冠状病毒病大流行期间治疗阿片类药物使用障碍的丁丙诺啡透皮贴剂处方
JAMA Intern Med. 2021 Apr 1;181(4):562-565. doi: 10.1001/jamainternmed.2020.7497.
3
Changes in Outpatient Buprenorphine Dispensing During the COVID-19 Pandemic.
在 COVID-19 大流行前后，纽约州医疗补助计划慢性疼痛患者阿片类药物过量的风险。
Prev Med. 2023 Dec;177:107789. doi: 10.1016/j.ypmed.2023.107789. Epub 2023 Nov 26.
4
Trends in Use of Medication to Treat Opioid Use Disorder During the COVID-19 Pandemic in 10 State Medicaid Programs.COVID-19 大流行期间 10 个州医疗补助计划中治疗阿片类药物使用障碍药物的使用趋势。
JAMA Health Forum. 2023 Jun 2;4(6):e231422. doi: 10.1001/jamahealthforum.2023.1422.
5
Trends in psychiatric diagnoses by COVID-19 infection and hospitalization among patients with and without recent clinical psychiatric diagnoses in New York city from March 2020 to August 2021.2020 年 3 月至 2021 年 8 月期间，纽约市有近期临床精神诊断和无近期临床精神诊断的患者因 COVID-19 感染和住院的精神科诊断趋势。
Transl Psychiatry. 2022 Nov 21;12(1):492. doi: 10.1038/s41398-022-02255-8.
新冠疫情期间门诊丁丙诺啡配药的变化。
JAMA. 2020 Dec 15;324(23):2442-2444. doi: 10.1001/jama.2020.22154.